| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/11/2004 | EP0835125B1 Cd4-derived peptides that inhibit immune responses |
| 02/11/2004 | CN1137722C Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens |
| 02/10/2004 | US6689751 Peptide comprising amino acid sequence 15 or 83 with alanine or alpha-aminoisobutyrate substitution |
| 02/10/2004 | US6689557 Method of identifying a substance that affects long term memory and CREM/CREB/ATF-1 subfamily members |
| 02/10/2004 | US6689363 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 02/10/2004 | CA2214247C Modulators of amyloid aggregation |
| 02/05/2004 | WO2004011946A1 Site-specific labelling of proteins using acridone and quinacridone lifetime dyes |
| 02/05/2004 | WO2004011902A2 Improved systems and methods for analysis of protein post-translational modification |
| 02/05/2004 | WO2004011650A2 Antigens encoded by alternative reading frame from pathogenic viruses |
| 02/05/2004 | WO2004011599A2 Polypeptide cleavage process |
| 02/05/2004 | WO2004011487A2 Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 02/05/2004 | WO2004011486A2 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |
| 02/05/2004 | WO2004011485A2 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 02/05/2004 | WO2004011483A2 Isolated, ssx-2 and ssx-2 related peptides useful as hla binders and ctl epitopes, and uses thereof |
| 02/05/2004 | WO2003097089A3 Attenuation of metapneumovirus |
| 02/05/2004 | WO2003072034A3 Cyclic peptides and analogs useful to treat allergies |
| 02/05/2004 | WO2003046137A3 Hiv envelope v3-ccr5 binding site immunogen |
| 02/05/2004 | WO2003037172A3 Endothelial-cell binding peptides for diagnosis and therapy |
| 02/05/2004 | WO2002100883A3 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same |
| 02/05/2004 | US20040024725 Regulated apoptosis |
| 02/05/2004 | US20040024179 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 02/05/2004 | US20040024176 Cyclic peptide tube |
| 02/05/2004 | US20040023862 Newly identified uses of BRS3 polypeptides and polynucleotides encoding such polypeptides, to their use in therapy of ischemia, of neurodegenerative diseases, of memory and attention disorders, and in identifying compounds which may be |
| 02/05/2004 | US20040023859 New melanocortin receptor ligands are cyclic peptide analogs that preferably exhibit selectivity for the MC-4 and/or the MC-3 receptors relative to the other melanocortin receptors |
| 02/05/2004 | US20040023856 Purified DNA comprising a sequence encoding a B1k chain of laminin. Vector comprising a DNA sequence encoding a B1k protein. |
| 02/05/2004 | US20040023853 Treatment or prevention of medical conditions associated with oligouric nephropathy, bone resorption, abnormal intestinal crypt cell proliferation or patency of the ductus arteriosus and the like are provided they are antagonist peptides |
| 02/05/2004 | US20040023414 Self-assembling peptide surfaces for cell patterning and interactions |
| 02/05/2004 | US20040023409 Reagents and methods that afford direct attachment of the acridine dye reporter to either the N-terminus or C-terminus of a synthetic or recombinant peptide or protein and their derivatives in a site-specific manner |
| 02/05/2004 | US20040022870 Immunogenic TLP composition |
| 02/05/2004 | DE10230141A1 Verfahren zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc) Method for the enrichment and detection of altered prion protein (PrPSc) |
| 02/05/2004 | CA2802205A1 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 02/05/2004 | CA2493798A1 Improved systems and methods for analysis of protein post-translational modification |
| 02/05/2004 | CA2493314A1 Site-specific labelling of proteins using acridone and quinacridone lifetime dyes |
| 02/05/2004 | CA2493306A1 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 02/05/2004 | CA2486795A1 Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 02/05/2004 | CA2484941A1 Antigens encoded by alternative reading frame from pathogenic viruses |
| 02/04/2004 | EP1386167A2 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 02/04/2004 | EP1385982A2 Methods and means for detecting enzymatic cleavage and linkage reactions |
| 02/04/2004 | EP1385958A2 Human tachykinin-related splice variants and compositions thereof |
| 02/04/2004 | EP1385882A2 Peptides and related molecules that bind to tall-1 |
| 02/04/2004 | EP1385873A2 A ligand for enhancing oral and cns delivery of biological agents |
| 02/04/2004 | EP1385872A1 Inhibitors of receptor activator of nf-kappa b and uses thereof |
| 02/04/2004 | EP1385870A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 02/04/2004 | EP1107998B1 Method for the preparation of polyamide chains of precise length, their conjugates with proteins |
| 02/04/2004 | CN1137136C Targeted cytotoxic anthracycline analogs |
| 02/04/2004 | CN1137135C Ribosome deactivating protein originating from octagon towel gourd |
| 02/04/2004 | CN1136916C Long-acting injection suspensions and process for their preparation |
| 02/04/2004 | CN1136915C Use of nona-and decapeptides in the preparation of drug for treatment of aids |
| 02/03/2004 | US6686454 Antibodies to specific regions of cyclosporine related compounds |
| 02/03/2004 | US6686445 Esterification of 2-hydroxyisovaleric acid and tboc-l-proline; salt formation with trifluoracetic acid; deprotecting and reacting with n,n'-dimethylvaline |
| 01/29/2004 | WO2004009637A1 Anti-angiogenic peptides |
| 01/29/2004 | WO2004009540A2 Methods and kits for transferases |
| 01/29/2004 | WO2004009110A1 Peptide m as apoptosis inducing agent |
| 01/29/2004 | WO2004009021A2 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | WO2003066663A3 Peptides for recognition and targeting of glial cell tumors |
| 01/29/2004 | WO2003048775A3 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 01/29/2004 | WO2003037912A3 Tri-, tetra-, and penta-peptides having antiangiogenic activity |
| 01/29/2004 | WO2002090503A3 Anti-microbial peptides and compositions |
| 01/29/2004 | WO2002077036A3 Recombinant production of polyanionic polymers, and uses thereof |
| 01/29/2004 | US20040019182 Reagents and methods for assaying Bacillus anthracis lethal factor protease |
| 01/29/2004 | US20040019181 Antimicrobial cationic peptides |
| 01/29/2004 | US20040019015 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss |
| 01/29/2004 | US20040018986 Viricide against hepatitis virus |
| 01/29/2004 | US20040018974 Multivalent constructs for therapeutic and diagnostic applications |
| 01/29/2004 | US20040018967 Ligand/lytic peptide compositions and methods of use |
| 01/29/2004 | US20040018961 Forming micelles in aqueous solution; adjustment pH; stabilization |
| 01/29/2004 | US20040018580 Serine protease complex; immobilization; anticancer, antitumor agents |
| 01/29/2004 | US20040018561 Peptide compounds and their use as protease substrates |
| 01/29/2004 | US20040018558 Method for identifying modulators of G protein coupled receptor signaling |
| 01/29/2004 | US20040018171 Biochemical conjugates comprising tumor necrosis factor or interferons and ligands of CD antigen receptors, used as anticarcinogenic agents |
| 01/29/2004 | CA2492598A1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | CA2492178A1 Exopeptidase-mediated unquenching of reporter substrates in assays for kinase and phosphatase activity |
| 01/28/2004 | EP1384725A2 Factor Xa inhibitors |
| 01/28/2004 | EP1384710A1 Synthesis of heterocyclic compounds containing five- or six-membered rings |
| 01/28/2004 | EP1383922A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 01/28/2004 | EP1383794A2 Daptomycin and related analogs in crystalline form, thier preparation and use |
| 01/28/2004 | EP1383793A2 Insulin and igf-1 receptor agonists and antagonists |
| 01/28/2004 | EP1383538A2 Oral absorbed drugs |
| 01/28/2004 | EP1383528A2 Epitope sequences |
| 01/28/2004 | EP1383480A2 Lipid-comprising drug delivery complexes and methods for their production |
| 01/28/2004 | EP1383393A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/28/2004 | EP0871428B1 Preparation used in dental care |
| 01/28/2004 | CN1471538A Peptide structures useful for competitive modulation of dipeptidyl peptidase IV catalysis |
| 01/28/2004 | CN1471526A Dioxolane analogs for improved inter-cellular delivery |
| 01/28/2004 | CN1136229C Action of proinsulin associated peptide on dopamine transporter and its application in treating correlative diseases |
| 01/27/2004 | US6683189 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 01/27/2004 | US6683158 Alpha-subunit of the Mac-1 leukocyte adhesion receptor |
| 01/27/2004 | US6683053 Insulin-like growth factor agonist molecules |
| 01/27/2004 | US6682897 Peptides derived from human heat protein 60 for treatment of diabetes, compositions, methods and kits |
| 01/22/2004 | WO2004007757A1 Method for identifying individual active entities from complex mixtures |
| 01/22/2004 | WO2004007746A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN |
| 01/22/2004 | WO2004007702A2 Modulators of chloride intracellular channel 1 protein signaling ____________________________________________________________ |
| 01/22/2004 | WO2004007671A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN |
| 01/22/2004 | WO2004007661A2 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 01/22/2004 | WO2004007535A1 Bicyclic oligopeptides and their use as glucagon receptor antagonists |
| 01/22/2004 | WO2004007524A2 Bicyclic oligopeptides |
| 01/22/2004 | WO2004006951A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 01/22/2004 | WO2003089457A3 Peptide inhibitors of protein kinase c ϝ for pain management |
| 01/22/2004 | WO2003076391A3 Urokinase inhibitors, production and use thereof |
| 01/22/2004 | WO2003054001A3 Method for preparing echinocandin derivatives and their compositions |